Neoadjuvant Nab-paclitaxel in Triple-negative or HER2-positive Breast Cancer
Conditions: Breast Cancer; Triple Negative Breast Cancer; HER2-positive Breast Cancer Interventions: Drug: Nab-paclitaxel; Drug: Carboplatin; Drug: Herceptin Sponsor: Ruijin Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Breast Cancer | Cancer | Cancer & Oncology | HER2 | Herceptin | Hospitals | Neoadjuvant Therapy | Research